Vor Biopharma, Inc. (VOR)
18.03
-1.31
(-6.77%)
USD |
NASDAQ |
Oct 16, 16:00
17.73
-0.30
(-1.66%)
After-Hours: 20:00
Vor Biopharma Market Cap : 981.84M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 981.84M |
| October 15, 2026 | 1.053B |
| October 14, 2026 | 1.021B |
| October 13, 2026 | 1.038B |
| October 12, 2026 | 1.078B |
| October 09, 2026 | 1.084B |
| October 08, 2026 | 1.042B |
| October 07, 2026 | 1.023B |
| October 06, 2026 | 997.09M |
| October 05, 2026 | 1.012B |
| October 02, 2026 | 1.018B |
| October 01, 2026 | 983.47M |
| September 30, 2026 | 1.039B |
| September 29, 2026 | 998.17M |
| September 28, 2026 | 997.09M |
| September 25, 2026 | 1.009B |
| September 24, 2026 | 1.004B |
| September 23, 2026 | 1.055B |
| September 22, 2026 | 1.198B |
| September 21, 2026 | 1.192B |
| September 18, 2026 | 1.165B |
| September 17, 2026 | 1.192B |
| September 16, 2026 | 1.195B |
| September 15, 2026 | 1.215B |
| September 14, 2026 | 1.257B |
| Date | Value |
|---|---|
| September 11, 2026 | 1.214B |
| September 10, 2026 | 1.217B |
| September 09, 2026 | 1.265B |
| September 08, 2026 | 1.367B |
| September 04, 2026 | 1.364B |
| September 03, 2026 | 1.320B |
| September 02, 2026 | 1.348B |
| September 01, 2026 | 1.233B |
| August 31, 2026 | 1.224B |
| August 28, 2026 | 1.233B |
| August 27, 2026 | 1.281B |
| August 26, 2026 | 1.289B |
| August 25, 2026 | 1.307B |
| August 24, 2026 | 1.237B |
| August 21, 2026 | 1.272B |
| August 20, 2026 | 1.256B |
| August 19, 2026 | 1.284B |
| August 18, 2026 | 1.268B |
| August 17, 2026 | 1.253B |
| August 14, 2026 | 1.254B |
| August 13, 2026 | 1.268B |
| August 12, 2026 | 1.217B |
| August 11, 2026 | 1.285B |
| August 10, 2026 | 1.273B |
| August 07, 2026 | 1.289B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 257.40M |
| Amgen, Inc. | 233.80B |
| Anika Therapeutics, Inc. | 267.39M |
| BioCryst Pharmaceuticals, Inc. | 1.989B |
| Imunon, Inc. | 4.759M |
Market Cap Related Metrics
| Price | 18.03 |
| Earnings Yield | -462.5% |